PROTOCOLS
The Regenesys Protocol Library
Conceptual Examples
Essential Hydration IV®
A foundational IV hydration protocol with essential vitamins and minerals for basic wellness support and hydration.
Key Components:
- Normal Saline Base
- B-Complex Vitamins
- Vitamin C
- Magnesium
Applications:
- General Hydration
- Wellness Maintenance
- Hangover Recovery
- Basic Nutrient Support
Avg. Patient Price: $299 | Physician Royalty/Use: $14.95
Innovation Value: Standardized formulation based on clinical guidelines
Evidence Level: Established standard of care
NAD+ Optimized Protocol®
A refined IV formulation designed to enhance cellular repair, energy metabolism, and cognitive function with reduced side effects and improved patient tolerance.
Key Components:
- NAD+ (Nicotinamide Adenine Dinucleotide)
- Myers Cocktail Base
- Glutathione Push
Applications:
- Longevity & Anti-Aging
- Neurodegenerative Support
- Addiction Recovery
- Athletic Recovery
Avg. Patient Price: $750 | Physician Royalty/Use: $52.50
Innovation Value: Enhanced formulation with improved bioavailability
Evidence Level: Clinical outcomes data from 127 patients
Exosome Facial Rejuvenation®
A comprehensive facial rejuvenation protocol using exosomes combined with microneedling and growth factors for enhanced skin regeneration and collagen production.
Key Components:
- Exosomes (20Billion particles)
- Growth Factor Serum
- Microneedling Application
- Customized post-procedure care
Applications:
- Facial Rejuvenation
- Scar Reduction
- Skin Texture Improvement
- Anti-Aaging Treatments
Avg. Patient Price: $1,800 | Physician Royalty/Use: $180
Innovation Value: Enhanced delivery system for improved results
Evidence Level: Clinical before/after data from 94 patients
AOD-9604 + CJC-1295 Body Composition Stack®
A synergistic peptide protocol targeting stubborn fat reduction and lean muscle growth through enhanced lipolysis and natural growth hormone secretion.
Key Components:
- AOD-9604 Fragment
- CJC-1295 (DAC)
- B12 Co-Factor
- Customized dosing sequence
Applications:
- Non-GLP-1 Weight Management
- Body Recomposition
- Metabolic Syndrome Support
Avg. Patient Price: $1,200 | Physician Royalty/Use: $150
Innovation Value: Novel combination with patented sequencing
Evidence Level: Peer-reviewed publication pending
Neuro-Regenerative IV Fusion®
A groundbreaking IV protocol combining exosomes, peptides, and nutrients specifically formulated to support neurological repair and cognitive enhancement.
Key Components:
- Exosomes (50Billion particles)
- Cerebrolysin Peptides
- NAD+ Complex
- Neuro-specific nutrient blend
- Proprietary activation sequence
Applications:
- Post-stroke Recovery
- Neurodegenerative Conditions
- Traumatic Brain Injury
- Cognitive Enhancement
Avg. Patient Price: $3,500 | Physician Royalty/Use: $525
Innovation Value: Multi-mechanism approach with published outcomes
Evidence Level: Randomized controlled trial data available
Our Multi-Dimensional Valuation System
We've developed a comprehensive approach to ensure physicians are fairly compensated for both their clinical expertise and innovative contributions. Protocol value is determined by multiple factors:
Component Costs
Market value of all included treatments and materials
Innovation Level
Novelty of the combination and treatment sequencing
Clinical Evidence
Strength of outcomes data supporting efficacy
Complexity & Expertise
Training required to safely administer the protocol
Market Exclusivity
Uniqueness and competitive advantage offered
Operational Support
Resources required for training and implementation
This multi-factor approach ensures that simple protocols are valued fairly while truly innovative combinations receive the premium compensation they deserve.
Rigorously Validated. Fairly Valued.
Every protocol in our library undergoes a multi-stage validation process by our Physician Advisory Board to ensure safety, efficacy, and commercial viability while determining appropriate valuation tier.
1. Submission & Initial Valuation
Physician submits methodology, component list, and evidence. Our system provides an initial tier assessment.
2. Clinical & Validation Review
Protocol is evaluated for innovation, evidence strength, and clinical validity by our advisory board.
3. Final Tier Assignment
Based on comprehensive assessment, protocol receives final tier placement and royalty percentage.
DISCLAIMER
- All protocol names, descriptions, and clinical data are fictional and created for demonstration purposes.
- Physician names and credentials are fictional and any resemblance to actual persons is coincidental.
- Adoption rates, patient prices, and royalty projections are estimates only for illustrative purposes.
- Protocol valuation tiers and royalty percentages are conceptual and subject to change.
- This interface does not constitute an offer to provide or license the depicted medical protocols.
- This demonstration is not intended to provide medical, financial, or legal advice. Users should consult with appropriate professionals before making any business decisions related to medical protocols or regenerative treatments.
- Regenesys Health Protocols makes no representations or warranties regarding the accuracy or completeness of any information presented in this demonstration interface.
INTELLECTUAL PROPERTY PROTECTION
In actual practice, all physician submissions would be protected by mutual Non-Disclosure Agreements (NDAs) to ensure the confidentiality of proprietary protocol information. The valuation process would occur only after appropriate confidentiality agreements are in place.
All Protocols
Peptide Therapies
IV & Nutrient Therapies
Exosome & Cellular
NAD+ Optimized Protocol®
Rigorously Validated. Ethically Sourced.
Key Components:
- NAD+ (Nicotinamide Adenine
- Dinucleotide)
- Myers Cocktail Base Glutathione Push
Applications:
- Longevity & Anti-Aging
- Neurodegenerative Support
- Addiction Recovery
- Athletic Recovery
Rigorously Validated. Ethically Sourced.
Submission & IRB Review
Physician submits complete methodology and preliminary data for ethical review.
If Necessary, Pilot Clinical Validation
Protocol is tested in a controlled pilot across 3 partner clinics.
Commercial Scaling
Upon success, protocol is branded, digitally packaged, and added to the global library.